As EGFR overexpression is associated with highly aggressive and metastatic tumor cells,34, 35 EGF-SubA+PDT combination might be particularly effective against primary invasive tumors either alone or in an adjuvant setting to surgery. The gene discussed is EGF; the disease is neoplasm.